Agilent Presents Thought Leader Award to Professor Hualiang Jiang
September 19 2019 - 1:00AM
Business Wire
Chinese Academy of Sciences scientist recognized for his work in
medicinal chemistry and drug discovery
Agilent Technologies Inc. (NYSE: A) announced today that
Professor Hualiang Jiang has received an Agilent Thought Leader
Award. Professor Jiang directs the Shanghai Institute of Materia
Medica at the Chinese Academy of Sciences and is a leading
researcher in the area of medicinal chemistry and computational
drug design.
Professor Jiang has a strong track record identifying new
targets for cancer therapy and designing inhibitors that block
protein-protein interactions. He and his collaborators designed the
first inhibitor of Atox1/CCS and used it to prove that copper
chaperones are potential new targets for anticancer therapies. They
also designed the first inhibitor of speckle-type POZ protein for
potential application to clear-cell renal cell carcinoma.
The Agilent Thought Leader Award will support Professor Jiang in
his latest research using novel glycoside-based small molecules to
test the potential benefits of an alternative class of inhibitors
of the PD-L1/PD-1pathway. His laboratory will measure and compare
the metabolic and pharmacologic effects of the small molecule
inhibitors against that of benchmark therapeutic PD-L1
antibodies.
“Agilent’s support for leading researchers like Professor Jiang
underscores our commitment to accelerating the development of
metabolomics and integrated biology workflows for cancer drug
discovery and characterization,” said Victor Chan, Agilent vice
president, and general manager of Laboratory Solutions for Agilent
Greater China.
“It is my great honor to receive an Agilent Thought Leader
Award. As a drug designer, I am interested in discovering novel
drug candidates from natural products, in particular, natural
carbohydrate compounds, against new drug targets,” said Professor
Jiang. “Computational drug design and chemical proteomics are the
major tools in my research platform. My research team will benefit
from the integration of metabolomics data.”
The Agilent Thought Leader Award program promotes fundamental
scientific advances by contributing financial support, products,
and expertise to the research of influential thought leaders in the
life sciences, diagnostics, and chemical analysis space. Further
information is available at the Agilent Thought Leader Award web
page.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life
sciences, diagnostics and applied chemical markets. With more than
50 years of insight and innovation, Agilent instruments, software,
services, solutions, and people provide trusted answers to
customers' most challenging questions. The company generated
revenues of $4.91 billion in fiscal 2018 and employs 15,550 people
worldwide. Information about Agilent is available at
www.agilent.com. To receive the latest Agilent news, subscribe to
our Newsroom. Follow Agilent on LinkedIn, Twitter, and
Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190918006010/en/
Naomi Goumillout Agilent Technologies, Inc. +1.781.266.2819
naomi.goumillout@agilent.com
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Sep 2024 to Oct 2024
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Oct 2023 to Oct 2024